The Latest in Aggressive Lymphomas

CHMP supports new indication for venetoclax

September 23, 2018

Stress linked to disease markers in CLL

September 20, 2018

NICE rejects DLBCL indication for CAR T-cell therapy

September 20, 2018

Guidelines for proton therapy in mediastinal lymphomas

September 19, 2018

Risks of watchful waiting in follicular lymphoma

September 19, 2018

MRD data added to venetoclax label

September 12, 2018

First CAR T-cell therapy approved in Canada

September 7, 2018

Regimens produce similar results in FL

September 7, 2018

Ibrutinib maintains efficacy over time

September 7, 2018

Predicting early outcomes in DLBCL

August 30, 2018

NICE says CAR T-cell therapy isn’t cost-effective

August 29, 2018

EC approves CAR T-cell therapy for DLBCL, PMBCL

August 28, 2018

EC approves CAR T-cell therapy for ALL, DLBCL

August 27, 2018

FDA approves new use for ibrutinib in WM

August 27, 2018

Combo produces high response rate in CLL

August 24, 2018